首页 > 最新文献

European Journal of Integrative Medicine最新文献

英文 中文
Attitudes of parents and primary care practitioners towards natural medicinal products (NMPs) for acute, uncomplicated upper respiratory tract infections and an NMP App: results from an online survey 家长和初级保健从业人员对用于急性、无并发症上呼吸道感染的天然药物(NMP)和NMP应用程序的态度:来自在线调查的结果
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-06-16 DOI: 10.1016/j.eujim.2025.102514
E. Belt-van Zoen , L. Veldman , N. van Steenbergen , M. Nieuwdorp , E. Baars

Introduction

Resistance to antibiotics is an increasing worldwide problem. Hence, identifying and implementing the use of alternatives to antibiotics is crucial. A prototype app providing evidence-based advice on the use of safe and effective natural medicinal products (NMPs) for acute, uncomplicated upper respiratory tract infections (URTIs) is being developed. This study investigates the acceptability of NMPs (for URTIs) and the idea of an NMP app among intended end-users.

Methods

An online survey was completed by parents (n = 103), general practitioners (GP; n = 110), nurse practitioners (n = 65), physician assistants (n = 65), and pharmacists (n = 71) working in Dutch primary care.

Results

The majority of parents (66–79 %) and professionals (40–98 %) reported past use, current recommendation, or future willingness to use NMPs for URTIs. The majority of respondents (73–82 %) indicated they would use or recommend an NMP app, with main reasons being convenience, practicality, and time-saving. Most important prerequisites for use were safety and effectiveness of the included NMPs. Pharmacists reported they would use an NMP app primarily for professional development and shared decision-making (both 53 %), whereas 72 % of parents and up to 57 % of other professionals would use it mainly to support self-management. Up to 61 % of respondents expected a reduction in antibiotic use, and up to 70 % anticipated fewer primary care visits for URTIs with the introduction of an NMP App.

Conclusions

This study indicates broad acceptance of NMPs for URTIs across intended end-user groups. An NMP app seems to be a well-supported tool for reducing antibiotic use and primary care visits for children with URTIs in Dutch primary care. However, a website or web-based tool may be more fitting than a standalone mobile application. Furthermore, to prevent the exacerbation of health inequalities, it is important to also develop tools that are accessible to parents with low (health) literacy and a lower socio-economic position. GP assistants and pharmacy assistants appear key end-users for further research and implementation.
抗生素耐药性是一个日益严重的世界性问题。因此,确定和实施抗生素替代品的使用至关重要。正在开发一个原型应用程序,为使用安全有效的天然药物(nmp)治疗急性无并发症上呼吸道感染(URTIs)提供循证建议。本研究调查了NMP(用于URTIs)的可接受性以及NMP应用程序在预期最终用户中的想法。方法对103名家长(n = 103)、全科医生(GP;n = 110),执业护士(n = 65),医师助理(n = 65)和药剂师(n = 71)在荷兰初级保健工作。结果大多数家长(66 - 79%)和专业人员(40 - 98%)报告了过去使用、目前推荐或未来愿意使用nmp治疗尿路感染。大多数受访者(73 - 82%)表示他们会使用或推荐NMP应用程序,主要原因是方便、实用和节省时间。使用最重要的先决条件是所纳入nmp的安全性和有效性。药剂师报告说,他们使用NMP应用程序主要是为了专业发展和共同决策(均为53%),而72%的父母和高达57%的其他专业人员主要使用它来支持自我管理。高达61%的受访者预计,随着NMP应用程序的引入,抗生素的使用将减少,高达70%的受访者预计,URTIs的初级保健就诊将减少。结论:本研究表明,NMP在预期的最终用户群体中被广泛接受。NMP应用程序似乎是一个得到良好支持的工具,可以减少荷兰初级保健中患有尿路感染的儿童的抗生素使用和初级保健就诊。然而,一个网站或基于web的工具可能比一个独立的移动应用程序更合适。此外,为了防止保健不平等的加剧,还必须开发工具,使(保健)知识普及程度低和社会经济地位较低的父母也能使用。全科医生助理和药房助理是进一步研究和实施的关键终端用户。
{"title":"Attitudes of parents and primary care practitioners towards natural medicinal products (NMPs) for acute, uncomplicated upper respiratory tract infections and an NMP App: results from an online survey","authors":"E. Belt-van Zoen ,&nbsp;L. Veldman ,&nbsp;N. van Steenbergen ,&nbsp;M. Nieuwdorp ,&nbsp;E. Baars","doi":"10.1016/j.eujim.2025.102514","DOIUrl":"10.1016/j.eujim.2025.102514","url":null,"abstract":"<div><h3>Introduction</h3><div>Resistance to antibiotics is an increasing worldwide problem. Hence, identifying and implementing the use of alternatives to antibiotics is crucial. A prototype app providing evidence-based advice on the use of safe and effective natural medicinal products (NMPs) for acute, uncomplicated upper respiratory tract infections (URTIs) is being developed. This study investigates the acceptability of NMPs (for URTIs) and the idea of an NMP app among intended end-users.</div></div><div><h3>Methods</h3><div>An online survey was completed by parents (<em>n</em> = 103), general practitioners (GP; <em>n</em> = 110), nurse practitioners (<em>n</em> = 65), physician assistants (<em>n</em> = 65), and pharmacists (<em>n</em> = 71) working in Dutch primary care.</div></div><div><h3>Results</h3><div>The majority of parents (66–79 %) and professionals (40–98 %) reported past use, current recommendation, or future willingness to use NMPs for URTIs. The majority of respondents (73–82 %) indicated they would use or recommend an NMP app, with main reasons being convenience, practicality, and time-saving. Most important prerequisites for use were safety and effectiveness of the included NMPs. Pharmacists reported they would use an NMP app primarily for professional development and shared decision-making (both 53 %), whereas 72 % of parents and up to 57 % of other professionals would use it mainly to support self-management. Up to 61 % of respondents expected a reduction in antibiotic use, and up to 70 % anticipated fewer primary care visits for URTIs with the introduction of an NMP App.</div></div><div><h3>Conclusions</h3><div>This study indicates broad acceptance of NMPs for URTIs across intended end-user groups. An NMP app seems to be a well-supported tool for reducing antibiotic use and primary care visits for children with URTIs in Dutch primary care. However, a website or web-based tool may be more fitting than a standalone mobile application. Furthermore, to prevent the exacerbation of health inequalities, it is important to also develop tools that are accessible to parents with low (health) literacy and a lower socio-economic position. GP assistants and pharmacy assistants appear key end-users for further research and implementation.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"78 ","pages":"Article 102514"},"PeriodicalIF":1.9,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144580292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The evolution of propolis research: A bibliometric analysis 蜂胶研究的演变:文献计量学分析
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-06-14 DOI: 10.1016/j.eujim.2025.102518
Tuğba Nigar Bozkuş

Introduction

Propolis is garnering increasing scientific and commercial interest due to its potential health benefits. Despite a surge in publications, a comprehensive overview of the propolis research landscape using bibliometric methods has been absent. This study aims to fill this gap by providing the first dedicated bibliometric analysis of global propolis research trends over the past two decades.

Methods

Data on propolis-related publications from 2004 to 2023 were retrieved from the Web of Science database. The R Bibliometrix package was employed to analyze publication trends, citation patterns, leading authors, institutions, countries, keyword co-occurrence, research themes, and collaboration networks.

Results

The analysis confirmed a substantial and consistent growth in propolis research. While publication volume is geographically concentrated (led by Brazil, China, Turkey), citation impact analysis revealed different patterns, with some countries (USA, Japan, Portugal, Bulgaria) demonstrating higher average citations per article, suggesting potential leadership in research quality or visibility. Thematic evolution mapping showed a clear trajectory from foundational studies focused on chemical composition and broad in vitro antioxidant/antimicrobial activity towards more sophisticated investigations into specific mechanisms (apoptosis, oxidative stress pathways), distinct propolis types (Brazilian green, stingless bee), and advanced applications (nanoparticles, nanofibers). Analysis identified central ‘’motor themes’’ (like chemical composition) requiring further development despite high interest, alongside highly developed ‘’niche themes’’ (like oxidative stress). Collaboration networks highlighted strong regional clusters but also opportunities for enhancing global integration, particularly bridging high-volume research hubs with high-impact centers.

Conclusion

This bibliometric analysis reveals propolis research as a dynamic, rapidly maturing, and increasingly interdisciplinary field. The divergence between publication quantity and citation impact, the clear evolution of research themes towards mechanistic depth, and the identification of specific developmental needs within the thematic structure offer critical strategic insights. The findings underscore a significant gap between the extensive preclinical investigation of biological activities of propolis and its translation into validated clinical applications. The findings advocate focused efforts on standardization, targeted international collaborations to leverage complementary strengths, and prioritizing clinical trials to substantiate the therapeutic potential suggested by the vast body of existing literature. This analysis provides an evidence-based roadmap to guide future research investments and collaborations effectively.
蜂胶由于其潜在的健康益处而获得越来越多的科学和商业兴趣。尽管出版物激增,蜂胶研究景观使用文献计量学方法的全面概述一直缺席。本研究旨在填补这一空白,提供了第一个专门的文献计量分析全球蜂胶研究趋势在过去的二十年。方法从Web of Science数据库中检索2004 - 2023年蜂胶相关文献资料。使用R Bibliometrix软件包分析出版趋势、引文模式、主要作者、机构、国家、关键词共现、研究主题和合作网络。结果分析证实了蜂胶研究的实质性和持续性增长。虽然出版物数量在地理上集中(以巴西、中国、土耳其为首),但引用影响分析显示出不同的模式,一些国家(美国、日本、葡萄牙、保加利亚)的每篇文章的平均引用率更高,表明在研究质量或知名度方面可能处于领先地位。主题进化图谱显示了清晰的轨迹,从专注于化学成分和广泛的体外抗氧化/抗菌活性的基础研究,到更复杂的特定机制(细胞凋亡、氧化应激途径)、不同蜂胶类型(巴西绿蜂胶、无刺蜂)和高级应用(纳米颗粒、纳米纤维)的研究。分析确定了需要进一步开发的核心“运动主题”(如化学成分),尽管人们对此很感兴趣,以及高度发达的“利基主题”(如氧化应激)。合作网络突出了强大的区域集群,但也为加强全球一体化提供了机会,特别是将高容量研究中心与高影响力中心连接起来。结论文献计量学分析表明蜂胶研究是一个动态的、迅速成熟的、跨学科的研究领域。出版物数量和引用影响之间的差异,研究主题向机制深度的明确演变,以及主题结构中特定发展需求的确定提供了关键的战略见解。这些发现强调了蜂胶生物活性的广泛临床前研究与其转化为有效的临床应用之间的重大差距。研究结果主张集中精力进行标准化,有针对性的国际合作,以利用互补优势,并优先进行临床试验,以证实大量现有文献所建议的治疗潜力。该分析提供了一个基于证据的路线图,以有效地指导未来的研究投资和合作。
{"title":"The evolution of propolis research: A bibliometric analysis","authors":"Tuğba Nigar Bozkuş","doi":"10.1016/j.eujim.2025.102518","DOIUrl":"10.1016/j.eujim.2025.102518","url":null,"abstract":"<div><h3>Introduction</h3><div>Propolis is garnering increasing scientific and commercial interest due to its potential health benefits. Despite a surge in publications, a comprehensive overview of the propolis research landscape using bibliometric methods has been absent. This study aims to fill this gap by providing the first dedicated bibliometric analysis of global propolis research trends over the past two decades.</div></div><div><h3>Methods</h3><div>Data on propolis-related publications from 2004 to 2023 were retrieved from the Web of Science database. The R Bibliometrix package was employed to analyze publication trends, citation patterns, leading authors, institutions, countries, keyword co-occurrence, research themes, and collaboration networks.</div></div><div><h3>Results</h3><div>The analysis confirmed a substantial and consistent growth in propolis research. While publication volume is geographically concentrated (led by Brazil, China, Turkey), citation impact analysis revealed different patterns, with some countries (USA, Japan, Portugal, Bulgaria) demonstrating higher average citations per article, suggesting potential leadership in research quality or visibility. Thematic evolution mapping showed a clear trajectory from foundational studies focused on chemical composition and broad in vitro antioxidant/antimicrobial activity towards more sophisticated investigations into specific mechanisms (apoptosis, oxidative stress pathways), distinct propolis types (Brazilian green, stingless bee), and advanced applications (nanoparticles, nanofibers). Analysis identified central ‘’motor themes’’ (like chemical composition) requiring further development despite high interest, alongside highly developed ‘’niche themes’’ (like oxidative stress). Collaboration networks highlighted strong regional clusters but also opportunities for enhancing global integration, particularly bridging high-volume research hubs with high-impact centers.</div></div><div><h3>Conclusion</h3><div>This bibliometric analysis reveals propolis research as a dynamic, rapidly maturing, and increasingly interdisciplinary field. The divergence between publication quantity and citation impact, the clear evolution of research themes towards mechanistic depth, and the identification of specific developmental needs within the thematic structure offer critical strategic insights. The findings underscore a significant gap between the extensive preclinical investigation of biological activities of propolis and its translation into validated clinical applications. The findings advocate focused efforts on standardization, targeted international collaborations to leverage complementary strengths, and prioritizing clinical trials to substantiate the therapeutic potential suggested by the vast body of existing literature. This analysis provides an evidence-based roadmap to guide future research investments and collaborations effectively.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"78 ","pages":"Article 102518"},"PeriodicalIF":1.9,"publicationDate":"2025-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144522386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility and acceptability of a yoga-based mind body intervention for women with a history of hypertensive disorder in pregnancy 以瑜伽为基础的身心干预对妊娠期高血压病史妇女的可行性和可接受性
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-06-14 DOI: 10.1016/j.eujim.2025.102499
Caroline A Smith , Kylie Barr , Angela Makris , Amanda Henry , Hannah Dahlen , Annemarie Hennessy , Alison Canty , Wendy Pickup

Introduction

Hypertensive disorders of pregnancy affect 5 to 10% of women and are a significant cause of perinatal morbidity and mortality. This group of women have been shown to have an elevated risk of cardiovascular disease (CVD) and premature mortality. There are currently no interventions specifically targeting this at-risk group of women to reduce relevant risk factors and improve outcomes. In other populations of individuals at high CVD risk, studies suggest yoga may be effective in reducing CVD risk. This study examined the feasibility of yoga in contributing to the management of blood pressure postpartum.

Methods

A feasibility study was conducted. The primary objective was to examine recruitment, adherence, satisfaction, and safety of the yoga intervention. Secondary objectives included change in blood pressure, serological measures, quality of life and anxiety. Women were eligible from five to seven months postpartum. An online yoga intervention was delivered over eight weeks.

Results

Ten women (16% of those eligible) were recruited. All women completed the intervention. Compliance with the clinical outcome assessments ranged between 70 and 90%. There was high fidelity with intervention engagement. There were no significant changes over time in any clinical outcome, although a trend to overall improved quality of life (p=0.06) was seen. There were no adverse reactions reported.

Conclusion

Although uptake was low, women engaged well with postpartum yoga. Further research on yoga is needed to test effectiveness for CVD risk reduction for women with hypertension in the postpartum setting, involving an appropriately powered randomised controlled trial. The study was registered with the Australian and New Zealand Clinical Trial Registry (Registration number ACTRN: 12622000450718).
妊娠期高血压疾病影响5%至10%的妇女,是围产期发病率和死亡率的重要原因。这组妇女患心血管疾病(CVD)和过早死亡的风险较高。目前还没有专门针对这一高危妇女群体的干预措施来减少相关风险因素和改善结果。在其他心血管疾病高风险人群中,研究表明瑜伽可能有效降低心血管疾病风险。本研究探讨了瑜伽对产后血压管理的可行性。方法进行可行性研究。主要目的是检查瑜伽干预的招募、依从性、满意度和安全性。次要目标包括血压、血清学指标、生活质量和焦虑的变化。妇女在产后5到7个月有资格。在线瑜伽干预持续了八周。结果共招募了10名女性(占符合条件的16%)。所有女性都完成了干预。临床结果评估的依从性在70%到90%之间。干预参与的保真度很高。虽然观察到总体生活质量改善的趋势(p=0.06),但随着时间的推移,任何临床结果都没有显著变化。无不良反应报告。结论虽然孕妇对产后瑜伽的接受程度较低,但她们对产后瑜伽的参与程度较高。需要进一步的研究来测试瑜伽对产后高血压妇女降低心血管疾病风险的有效性,包括适当的随机对照试验。该研究已在澳大利亚和新西兰临床试验注册中心注册(注册号ACTRN: 12622000450718)。
{"title":"Feasibility and acceptability of a yoga-based mind body intervention for women with a history of hypertensive disorder in pregnancy","authors":"Caroline A Smith ,&nbsp;Kylie Barr ,&nbsp;Angela Makris ,&nbsp;Amanda Henry ,&nbsp;Hannah Dahlen ,&nbsp;Annemarie Hennessy ,&nbsp;Alison Canty ,&nbsp;Wendy Pickup","doi":"10.1016/j.eujim.2025.102499","DOIUrl":"10.1016/j.eujim.2025.102499","url":null,"abstract":"<div><h3>Introduction</h3><div>Hypertensive disorders of pregnancy affect 5 to 10% of women and are a significant cause of perinatal morbidity and mortality. This group of women have been shown to have an elevated risk of cardiovascular disease (CVD) and premature mortality. There are currently no interventions specifically targeting this at-risk group of women to reduce relevant risk factors and improve outcomes. In other populations of individuals at high CVD risk, studies suggest yoga may be effective in reducing CVD risk. This study examined the feasibility of yoga in contributing to the management of blood pressure postpartum.</div></div><div><h3>Methods</h3><div>A feasibility study was conducted. The primary objective was to examine recruitment, adherence, satisfaction, and safety of the yoga intervention. Secondary objectives included change in blood pressure, serological measures, quality of life and anxiety. Women were eligible from five to seven months postpartum. An online yoga intervention was delivered over eight weeks.</div></div><div><h3>Results</h3><div>Ten women (16% of those eligible) were recruited. All women completed the intervention. Compliance with the clinical outcome assessments ranged between 70 and 90%. There was high fidelity with intervention engagement. There were no significant changes over time in any clinical outcome, although a trend to overall improved quality of life (p=0.06) was seen. There were no adverse reactions reported.</div></div><div><h3>Conclusion</h3><div>Although uptake was low, women engaged well with postpartum yoga. Further research on yoga is needed to test effectiveness for CVD risk reduction for women with hypertension in the postpartum setting, involving an appropriately powered randomised controlled trial. The study was registered with the Australian and New Zealand Clinical Trial Registry (Registration number ACTRN: 12622000450718).</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"78 ","pages":"Article 102499"},"PeriodicalIF":1.9,"publicationDate":"2025-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144653321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Training needs for (UK) professional standards authority accredited register and regulated traditional, complementary and integrative medicine professions for supporting patients to make lifestyle and health behaviour changes: A rapid narrative review (联合王国)专业标准管理局认可、注册和管理的传统、补充和综合医学专业人员的培训需求,以支持患者改变生活方式和健康行为:快速叙述审查
IF 1.7 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-06-12 DOI: 10.1016/j.eujim.2025.102517
Jonquil Pinto, Katie Read, Ella Tarabey, Felicity L. Bishop

Introduction

Improving healthy lifestyles is a public health priority. Traditional, Complementary and Integrative medicine (TCIM) providers, and certain professions on the UK Professional Standards Authority (PSA) Accredited Registers (AR) may be well-placed to contribute - some TCIM professions already support patients to make behaviour changes. We aimed to map the landscape of training for PSA AR and regulated TCIM practitioners working with individuals to support lifestyle changes, including current provision, gaps and training needs.

Methods

We conducted a rapid narrative review of training within PSA AR and regulated TCIM professions. We searched research databases for articles exploring perceptions, experiences and responses to training (for supporting behaviour change) and searched websites of UK professional bodies for educational guidelines for pre-qualification education. We conducted systematic data searching and extraction, quality appraisal and produced a narrative synthesis of research and guidelines which identified patterns across professions.

Results

We identified 24 education guidelines (4 were unlocated). A total of 548 research studies were identified from database searches, and we identified 5 further studies. A total of 20 full-text articles were retrieved, 7 were excluded, leaving 13 in the review. While 22 of 24 guidelines mentioned lifestyle or health behaviour, only 4 (chiropractic, nutritional therapy, osteopathy and acupuncture) provided any detailed recommendations about how to support patients to make health behaviour changes (e.g. providing written information or recording/monitoring progress). Eight of the 13 research studies focussed on chiropractic; most studies focussed on physical activity, two on smoking cessation, and several looked at training in broad techniques including motivational interviewing. Practitioners in research studies were generally positive about training in lifestyle and health behaviour change and there was some evidence that such training enhances practitioner self-efficacy or skills.

Conclusions

Most evidence of engagement with supporting lifestyle/behaviour change is within four professions: chiropractic, osteopathy, nutritional therapy and acupuncture. To build on existing knowledge and practice, future training for chiropractors, osteopaths, nutritional therapists and acupuncturists could target the capabilities (e.g. knowledge, skills, decision-making), opportunities (e.g. resources) and motivations (e.g. social/professional role) of practitioners. Future research should also evaluate the impact of practitioner training on patients’ lifestyle and health behaviours.
改善健康的生活方式是公共卫生的优先事项。传统、补充和综合医学(TCIM)提供者以及英国专业标准局(PSA)认可登记册(AR)上的某些专业可能会做出很好的贡献——一些TCIM专业已经支持患者做出行为改变。我们的目标是绘制PSA AR和受监管的TCIM从业人员与个人合作以支持生活方式改变的培训景观,包括目前的供应,差距和培训需求。方法我们对PSA AR和受监管的TCIM专业人员的培训进行了快速回顾。我们在研究数据库中搜索了探讨对培训(支持行为改变)的看法、经验和反应的文章,并在英国专业机构的网站上搜索了资格预审教育的教育指南。我们进行了系统的数据搜索和提取,质量评估,并产生了一个研究的叙述性综合和指导方针,以确定跨专业的模式。结果我们确定了24条教育指南(其中4条没有定位)。从数据库检索中共确定了548项研究,我们确定了5项进一步的研究。共检索到20篇全文文章,排除7篇,纳入综述13篇。虽然24项指南中有22项提到了生活方式或健康行为,但只有4项(脊椎指压疗法、营养疗法、整骨疗法和针灸)提供了关于如何支持患者改变健康行为的详细建议(例如提供书面信息或记录/监测进展)。13项研究中有8项关注脊椎指压疗法;大多数研究关注的是体育锻炼,两项研究关注的是戒烟,还有几项研究关注的是包括动机性访谈在内的广泛技术培训。研究中的从业人员对改变生活方式和健康行为的培训普遍持积极态度,有一些证据表明,这种培训提高了从业人员的自我效能或技能。结论:大多数支持生活方式/行为改变的证据来自四个专业:脊椎指压疗法、整骨疗法、营养疗法和针灸。在现有知识和实践的基础上,未来对脊医、整骨治疗师、营养治疗师和针灸师的培训可以针对从业者的能力(如知识、技能、决策)、机会(如资源)和动机(如社会/专业角色)。未来的研究还应评估从业人员培训对患者生活方式和健康行为的影响。
{"title":"Training needs for (UK) professional standards authority accredited register and regulated traditional, complementary and integrative medicine professions for supporting patients to make lifestyle and health behaviour changes: A rapid narrative review","authors":"Jonquil Pinto,&nbsp;Katie Read,&nbsp;Ella Tarabey,&nbsp;Felicity L. Bishop","doi":"10.1016/j.eujim.2025.102517","DOIUrl":"10.1016/j.eujim.2025.102517","url":null,"abstract":"<div><h3>Introduction</h3><div>Improving healthy lifestyles is a public health priority. Traditional, Complementary and Integrative medicine (TCIM) providers, and certain professions on the UK Professional Standards Authority (PSA) Accredited Registers (AR) may be well-placed to contribute - some TCIM professions already support patients to make behaviour changes. We aimed to map the landscape of training for PSA AR and regulated TCIM practitioners working with individuals to support lifestyle changes, including current provision, gaps and training needs.</div></div><div><h3>Methods</h3><div>We conducted a rapid narrative review of training within PSA AR and regulated TCIM professions. We searched research databases for articles exploring perceptions, experiences and responses to training (for supporting behaviour change) and searched websites of UK professional bodies for educational guidelines for pre-qualification education. We conducted systematic data searching and extraction, quality appraisal and produced a narrative synthesis of research and guidelines which identified patterns across professions.</div></div><div><h3>Results</h3><div>We identified 24 education guidelines (4 were unlocated). A total of 548 research studies were identified from database searches, and we identified 5 further studies. A total of 20 full-text articles were retrieved, 7 were excluded, leaving 13 in the review. While 22 of 24 guidelines mentioned lifestyle or health behaviour, only 4 (chiropractic, nutritional therapy, osteopathy and acupuncture) provided any detailed recommendations about how to support patients to make health behaviour changes (e.g. providing written information or recording/monitoring progress). Eight of the 13 research studies focussed on chiropractic; most studies focussed on physical activity, two on smoking cessation, and several looked at training in broad techniques including motivational interviewing. Practitioners in research studies were generally positive about training in lifestyle and health behaviour change and there was some evidence that such training enhances practitioner self-efficacy or skills.</div></div><div><h3>Conclusions</h3><div>Most evidence of engagement with supporting lifestyle/behaviour change is within four professions: chiropractic, osteopathy, nutritional therapy and acupuncture. To build on existing knowledge and practice, future training for chiropractors, osteopaths, nutritional therapists and acupuncturists could target the capabilities (e.g. knowledge, skills, decision-making), opportunities (e.g. resources) and motivations (e.g. social/professional role) of practitioners. Future research should also evaluate the impact of practitioner training on patients’ lifestyle and health behaviours.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"78 ","pages":"Article 102517"},"PeriodicalIF":1.7,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144772378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diterpenoids from Croton tonkinensis Gagnep as antitumor agents: A systematic review 巴豆中二萜类抗肿瘤物质的系统综述
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-06-10 DOI: 10.1016/j.eujim.2025.102513
Vo Linh Tu , Tran Thi Thuy Quynh , Nghiem Dinh Van An , Nguyen Le Linh Chi

Introduction

Traditional Vietnamese medicine has a long history of using Kho sam (Croton tonkinensis Gagnep) in the treatment of various cancers. Kho sam is an ingredient in numerous remedies for salivary gland cancer, bronchial-lung cancer, colorectal cancer, and liver cancer. This systematic review aims to comprehensively evaluate the existing literature on diterpenoids isolated from C. tonkinensis and their antitumor activities.

Methods

The protocol for this systematic review was registered in PROSPERO (CRD42024579468). A search was performed on PubMed, Virtual Health Library (VHL), Global Health Library (GHL), and Google Scholar on September 13, 2024. Two independent members conducted the steps of screening the article, scoring the risk of bias for the article, extracting and writing the results. Due to heterogeneity among the included studies, the results were narrative and no meta-analyses were conducted.

Results

From an initial retrieval of 500 articles, 11 met the inclusion criteria. These studies investigated thirty-seven different compounds, among which ent-kaurane diterpenoids with the 16-en-15-one functional group and 8,9-seco-ent-kaurane diterpenoids exhibited particularly cytotoxic effects. These effects were mediated through several molecular pathways, including protein kinase B, hypoxia-inducible factor-dependent transcription, heat shock protein, extracellular signal-regulating kinase 1/2, and AMP-activated protein kinase pathways.

Conclusions

Current literature highlights kongensin D, derived from C. tonkinensis, as the most promising candidate, demonstrating high anticancer activity and selectivity, along with in vivo antitumor potential and a favorable safety profile.
越南传统医学使用Kho sam (Croton tonkinensis Gagnep)治疗各种癌症的历史悠久。Kho sam是许多治疗唾液腺癌、支气管肺癌、结肠直肠癌和肝癌的成分。本系统综述旨在综合评价现有文献中有关冬棘二萜类化合物及其抗肿瘤活性的研究进展。方法本系统评价的方案在PROSPERO注册(CRD42024579468)。我们于2024年9月13日在PubMed、Virtual Health Library (VHL)、Global Health Library (GHL)和谷歌Scholar上进行了检索。两名独立成员进行了文章筛选、文章偏倚风险评分、提取和撰写结果的步骤。由于纳入的研究存在异质性,研究结果为叙述性,未进行meta分析。结果在初步检索的500篇文献中,有11篇符合纳入标准。研究了37种不同的化合物,其中具有16-烯-15- 1官能团的对kaurane二萜和8,9-seco- kaurane二萜具有特别的细胞毒性作用。这些作用是通过多种分子途径介导的,包括蛋白激酶B、缺氧诱导因子依赖性转录、热休克蛋白、细胞外信号调节激酶1/2和amp激活的蛋白激酶途径。结论目前的研究表明,从东金草中提取的kongensin D是最有希望的候选药物,具有较高的抗肿瘤活性和选择性,以及良好的体内抗肿瘤潜力和良好的安全性。
{"title":"Diterpenoids from Croton tonkinensis Gagnep as antitumor agents: A systematic review","authors":"Vo Linh Tu ,&nbsp;Tran Thi Thuy Quynh ,&nbsp;Nghiem Dinh Van An ,&nbsp;Nguyen Le Linh Chi","doi":"10.1016/j.eujim.2025.102513","DOIUrl":"10.1016/j.eujim.2025.102513","url":null,"abstract":"<div><h3>Introduction</h3><div>Traditional Vietnamese medicine has a long history of using Kho sam (<em>Croton tonkinensis</em> Gagnep) in the treatment of various cancers. Kho sam is an ingredient in numerous remedies for salivary gland cancer, bronchial-lung cancer, colorectal cancer, and liver cancer. This systematic review aims to comprehensively evaluate the existing literature on diterpenoids isolated from <em>C. tonkinensis</em> and their antitumor activities.</div></div><div><h3>Methods</h3><div>The protocol for this systematic review was registered in PROSPERO (CRD42024579468). A search was performed on PubMed, Virtual Health Library (VHL), Global Health Library (GHL), and Google Scholar on September 13, 2024. Two independent members conducted the steps of screening the article, scoring the risk of bias for the article, extracting and writing the results. Due to heterogeneity among the included studies, the results were narrative and no meta-analyses were conducted.</div></div><div><h3>Results</h3><div>From an initial retrieval of 500 articles, 11 met the inclusion criteria. These studies investigated thirty-seven different compounds, among which <em>ent</em>-kaurane diterpenoids with the 16-en-15-one functional group and 8,9-seco-<em>ent</em>-kaurane diterpenoids exhibited particularly cytotoxic effects. These effects were mediated through several molecular pathways, including protein kinase B, hypoxia-inducible factor-dependent transcription, heat shock protein, extracellular signal-regulating kinase 1/2, and AMP-activated protein kinase pathways.</div></div><div><h3>Conclusions</h3><div>Current literature highlights kongensin D, derived from <em>C. tonkinensis</em>, as the most promising candidate, demonstrating high anticancer activity and selectivity, along with <em>in vivo</em> antitumor potential and a favorable safety profile.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"78 ","pages":"Article 102513"},"PeriodicalIF":1.9,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144580177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Japanese traditional medication on males with diarrhea-predominant irritable bowel syndrome and gut microbiome: A single-arm prospective study 日本传统药物对男性腹泻型肠易激综合征和肠道微生物组的影响:一项单臂前瞻性研究
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-06-07 DOI: 10.1016/j.eujim.2025.102512
Ryutaro Arita , Shin Takayama , Toru Tamahara , Yuichi Aoki , Soichiro Kaneko , Akiko Kikuchi , Junko Kawashima , Yoshiyuki Kasahara , Kota Ishizawa , Ritsuko Shimizu , Tadashi Ishii

Introduction

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a common disorder of gut-brain interaction. In Japan, IBS-D is treated using Japanese traditional medicine (Kampo medicine); however, its clinical effects and influence on the gut microbiome are unknown. The purpose of this study was 1) to compare the characteristics of IBS-D patients with healthy controls (HCs), and 2) to investigate the effect of Kampo medicine on the symptoms and gut microbiome of patients with IBS-D.

Methods

We conducted two studies stepwise. First, we compared the clinical characteristics and gut microbiome of the patients with IBS-D to HCs. Second, we conducted a single-arm prospective clinical study to investigate the effectiveness and safety of Kampo treatment for IBS-D and its effects on gut microbiome alterations in patients with IBS-D. Newly diagnosed male patients with IBS-D received a four-week Kampo treatment (hangeshashinto or rikkunshito). Data on overall clinical improvement, scores on quality of life (QOL), gastrointestinal symptoms, diarrhea, anxiety, and depression were obtained. Fecal microbiomes were analyzed at four time points: (1) before treatment with remission; (2) before treatment with exacerbation; (3) after treatment; and (4) four weeks after treatment.

Results

Study 1: No significant difference was observed in the variety of gut microbiome (alpha diversity) between HCs and IBS-D patients. Study 2: After treatment, 81 % of the patients with IBS-D showed clinical improvement. Compared with the baseline, significant improvement was observed in IBS-related QOL, diarrhea, and trait anxiety scores after treatment and after follow-up, with no adverse effects. Microbiome analysis revealed significantly increased alpha diversity, decreased Blautia abundance, and increased Oscillospira abundance after treatment and 4 weeks after treatment compared with those during the exacerbation period before Kampo treatment.

Conclusion

Our study shows that no significant difference was observed in gut microbiome diversity between the patients with IBS-D and HCs. After Kampo treatment, abdominal symptoms and anxiety in male IBS-D patients were observed to improve and microbial diversity with specific microbial alterations appeared to be restored. These findings suggest that Kampo medicine could be considered as a potential approach for the symptoms and dysbiosis of IBS-D.
腹泻型肠易激综合征(IBS-D)是一种常见的肠-脑相互作用疾病。在日本,IBS-D的治疗使用日本传统药物(汉布药);然而,其临床效果和对肠道微生物组的影响尚不清楚。本研究的目的是1)比较IBS-D患者与健康对照组(hc)的特点,2)探讨汉方药对IBS-D患者症状和肠道菌群的影响。方法分步进行两项研究。首先,我们比较了IBS-D和hc患者的临床特征和肠道微生物组。其次,我们进行了一项单臂前瞻性临床研究,以研究Kampo治疗IBS-D的有效性和安全性及其对IBS-D患者肠道微生物组改变的影响。新诊断为IBS-D的男性患者接受为期四周的Kampo治疗(hangeshashinto或rikkunshito)。获得总体临床改善、生活质量(QOL)评分、胃肠道症状、腹泻、焦虑和抑郁的数据。在4个时间点分析粪便微生物组:(1)治疗前缓解;(2)治疗前伴有加重;(3)处理后;(4)治疗后4周。结果研究1:hc和IBS-D患者肠道微生物组多样性(α多样性)无显著差异。研究2:治疗后,81%的IBS-D患者出现临床改善。与基线相比,治疗后和随访后,ibs相关生活质量、腹泻和特质焦虑评分均有显著改善,无不良反应。微生物组分析显示,与Kampo治疗前加重期相比,治疗后和治疗后4周,α多样性显著增加,Blautia丰度降低,Oscillospira丰度增加。结论本研究显示IBS-D患者与hc患者肠道微生物多样性无显著差异。Kampo治疗后,男性IBS-D患者的腹部症状和焦虑得到改善,微生物多样性得到恢复,并出现特定的微生物改变。这些发现表明,汉布药可以被认为是治疗IBS-D症状和生态失调的潜在途径。
{"title":"Effect of Japanese traditional medication on males with diarrhea-predominant irritable bowel syndrome and gut microbiome: A single-arm prospective study","authors":"Ryutaro Arita ,&nbsp;Shin Takayama ,&nbsp;Toru Tamahara ,&nbsp;Yuichi Aoki ,&nbsp;Soichiro Kaneko ,&nbsp;Akiko Kikuchi ,&nbsp;Junko Kawashima ,&nbsp;Yoshiyuki Kasahara ,&nbsp;Kota Ishizawa ,&nbsp;Ritsuko Shimizu ,&nbsp;Tadashi Ishii","doi":"10.1016/j.eujim.2025.102512","DOIUrl":"10.1016/j.eujim.2025.102512","url":null,"abstract":"<div><h3>Introduction</h3><div>Diarrhea-predominant irritable bowel syndrome (IBS-D) is a common disorder of gut-brain interaction. In Japan, IBS-D is treated using Japanese traditional medicine (Kampo medicine); however, its clinical effects and influence on the gut microbiome are unknown. The purpose of this study was 1) to compare the characteristics of IBS-D patients with healthy controls (HCs), and 2) to investigate the effect of Kampo medicine on the symptoms and gut microbiome of patients with IBS-D.</div></div><div><h3>Methods</h3><div>We conducted two studies stepwise. First, we compared the clinical characteristics and gut microbiome of the patients with IBS-D to HCs. Second, we conducted a single-arm prospective clinical study to investigate the effectiveness and safety of Kampo treatment for IBS-D and its effects on gut microbiome alterations in patients with IBS-D. Newly diagnosed male patients with IBS-D received a four-week Kampo treatment (hangeshashinto or rikkunshito). Data on overall clinical improvement, scores on quality of life (QOL), gastrointestinal symptoms, diarrhea, anxiety, and depression were obtained. Fecal microbiomes were analyzed at four time points: (1) before treatment with remission; (2) before treatment with exacerbation; (3) after treatment; and (4) four weeks after treatment.</div></div><div><h3>Results</h3><div>Study 1: No significant difference was observed in the variety of gut microbiome (alpha diversity) between HCs and IBS-D patients. Study 2: After treatment, 81 % of the patients with IBS-D showed clinical improvement. Compared with the baseline, significant improvement was observed in IBS-related QOL, diarrhea, and trait anxiety scores after treatment and after follow-up, with no adverse effects. Microbiome analysis revealed significantly increased alpha diversity, decreased <em>Blautia</em> abundance, and increased <em>Oscillospira</em> abundance after treatment and 4 weeks after treatment compared with those during the exacerbation period before Kampo treatment.</div></div><div><h3>Conclusion</h3><div>Our study shows that no significant difference was observed in gut microbiome diversity between the patients with IBS-D and HCs. After Kampo treatment, abdominal symptoms and anxiety in male IBS-D patients were observed to improve and microbial diversity with specific microbial alterations appeared to be restored. These findings suggest that Kampo medicine could be considered as a potential approach for the symptoms and dysbiosis of IBS-D.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"78 ","pages":"Article 102512"},"PeriodicalIF":1.9,"publicationDate":"2025-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144580290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knowledge, attitude, and practice towards traditional Chinese medicine treatment among patients with polycystic ovary syndrome: A cross-sectional study 多囊卵巢综合征患者中医治疗知识、态度与行为的横断面研究
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-06-06 DOI: 10.1016/j.eujim.2025.102498
Nan Li , Lijun Wang , Hui Zhang , Yudong Zhang , Yuan Pang , Xiaoyue Lang , Yue Yang , Xiaoying Zhao , Xuke Zhang , Wenxi Yin , Yuqi Leng , Jun Bai

Introduction

This study aimed to evaluate the knowledge, attitude, and practice of patients with polycystic ovary syndrome (PCOS) regarding Traditional Chinese Medicine (TCM) treatment for PCOS.

Methods

This cross-sectional study was conducted among patients with PCOS at the Gynecology Outpatient Department and Reproductive Medicine Center of our hospital between January and May 2024. A self-reported questionnaire was used to assess demographic information, knowledge, attitude, and practice scores toward TCM treatment of PCOS. A threshold of ≥70.0 % of the maximum possible score was set for adequate knowledge, positive attitude, and proactive practice

Results

A total of 519 patients completed the questionnaire, 90.4 % aged 18-35. The mean scores for knowledge, attitude, and practice were 7.13 ± 5.41 (range 0-25), 30.74 ± 4.04 (range 8-40), and 16.95 ± 3.63 (range 5-25), respectively. The results of Spearman correlation analysis showed that knowledge score was correlated to the attitude (r = 0.272, P < 0.001) and practice (r = 0.421, P < 0.001) scores. The attitude score was correlated to the practice score (r = 0.410, P < 0.001). The Structural Equation Modeling showed that knowledge directly influenced attitude (β = 0.336, P < 0.001). Attitude directly influenced practice (β = 0.432, P < 0.001).

Conclusions

The patients exhibited inadequate knowledge, positive attitude, and proactive practice regarding TCM for PCOS. We recommend improving awareness and acceptance of TCM among patients with PCOS through targeted education, enhanced doctor-patient communication, and promotion of effective treatment models to enhance their quality of life.
本研究旨在了解多囊卵巢综合征(PCOS)患者对中医治疗的认知、态度和实践情况。方法对2024年1 - 5月在我院妇科门诊和生殖医学中心就诊的多囊卵巢综合征患者进行横断面研究。采用自填问卷对中医治疗多囊卵巢综合征的人口学信息、知识、态度和实践进行评估。充分的知识、积极的态度和积极的实践设定了≥70.0%的最大可能得分阈值。结果共519例患者完成了问卷,90.4%的患者年龄在18-35岁之间。知识、态度和实践的平均得分分别为7.13±5.41分(0 ~ 25分)、30.74±4.04分(8 ~ 40分)和16.95±3.63分(5 ~ 25分)。Spearman相关分析结果显示,知识得分与态度存在显著相关(r = 0.272, P <;0.001)和实践(r = 0.421, P <;0.001)分数。态度得分与练习得分呈显著相关(r = 0.410, P <;0.001)。结构方程模型显示知识直接影响态度(β = 0.336, P <;0.001)。态度直接影响练习(β = 0.432, P <;0.001)。结论患者对中医治疗PCOS的认识不足,态度积极,积极主动。我们建议通过有针对性的教育,加强医患沟通,推广有效的治疗模式,提高PCOS患者对中医的认识和接受度,以提高他们的生活质量。
{"title":"Knowledge, attitude, and practice towards traditional Chinese medicine treatment among patients with polycystic ovary syndrome: A cross-sectional study","authors":"Nan Li ,&nbsp;Lijun Wang ,&nbsp;Hui Zhang ,&nbsp;Yudong Zhang ,&nbsp;Yuan Pang ,&nbsp;Xiaoyue Lang ,&nbsp;Yue Yang ,&nbsp;Xiaoying Zhao ,&nbsp;Xuke Zhang ,&nbsp;Wenxi Yin ,&nbsp;Yuqi Leng ,&nbsp;Jun Bai","doi":"10.1016/j.eujim.2025.102498","DOIUrl":"10.1016/j.eujim.2025.102498","url":null,"abstract":"<div><h3>Introduction</h3><div>This study aimed to evaluate the knowledge, attitude, and practice of patients with polycystic ovary syndrome (PCOS) regarding Traditional Chinese Medicine (TCM) treatment for PCOS.</div></div><div><h3>Methods</h3><div>This cross-sectional study was conducted among patients with PCOS at the Gynecology Outpatient Department and Reproductive Medicine Center of our hospital between January and May 2024. A self-reported questionnaire was used to assess demographic information, knowledge, attitude, and practice scores toward TCM treatment of PCOS. A threshold of ≥70.0 % of the maximum possible score was set for adequate knowledge, positive attitude, and proactive practice</div></div><div><h3>Results</h3><div>A total of 519 patients completed the questionnaire, 90.4 % aged 18-35. The mean scores for knowledge, attitude, and practice were 7.13 ± 5.41 (range 0-25), 30.74 ± 4.04 (range 8-40), and 16.95 ± 3.63 (range 5-25), respectively. The results of Spearman correlation analysis showed that knowledge score was correlated to the attitude (r = 0.272, P &lt; 0.001) and practice (r = 0.421, P &lt; 0.001) scores. The attitude score was correlated to the practice score (r = 0.410, P &lt; 0.001). The Structural Equation Modeling showed that knowledge directly influenced attitude (β = 0.336, P &lt; 0.001). Attitude directly influenced practice (β = 0.432, P &lt; 0.001).</div></div><div><h3>Conclusions</h3><div>The patients exhibited inadequate knowledge, positive attitude, and proactive practice regarding TCM for PCOS. We recommend improving awareness and acceptance of TCM among patients with PCOS through targeted education, enhanced doctor-patient communication, and promotion of effective treatment models to enhance their quality of life.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"78 ","pages":"Article 102498"},"PeriodicalIF":1.9,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144580291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meta-analysis and trial sequential analysis of Huaiqihuang granules in treatment of cough variant asthma in pediatrics 怀芪黄颗粒治疗小儿咳嗽变异性哮喘的meta分析和试验序贯分析
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-06-05 DOI: 10.1016/j.eujim.2025.102511
Qiaoling Li, Jing Peng, Linhui Liu

Introduction

Many individuals with cough variant asthma (CVA) utilize Huaiqihuang granules to alleviate symptoms. However, there is a lack of systematic reviews investigating its efficacy and safety for CVA.

Methods

A computer-based retrieval of various databases was conducted to search for randomized controlled trials (RCTs) on the treatment of CVA in children using Huaiqihuang granules combined with Western medicine. The search encompassed eight databases, including China National Knowledge Infrastructure (CNKI), Wangfang, VIP (VIP Information Co.Ltd.), PubMed, Web of Science, The Cochrane Library, Embase, and Sinomed database, and covered literature up to April 2025. Articles were screened and selected based on predefined inclusion and exclusion criteria. The quality of the included articles was assessed, followed by a meta-analysis using RevMan5.3. The quality of evidence was graded using the Grade of Recommendations Assessment, Development, and Evaluation (GRADE) system. Additionally, trial sequential analysis (TSA) was performed using TSA 0.9.5.10 beta software.

Results

A total of 17 RCTs were included in the analysis, encompassing a total sample size of 1,742 patients. Results showed that the combination of Huaiqihuang granules with conventional Western medicine significantly enhanced clinical efficacy and reduced recurrence rates compared to Western medicine alone. This combination also improved immune parameters, including CD4+/CD8+, and modulated inflammatory markers such as inflammatory factors interleukin-4 (IL-4) and interferon-gamma (IFN-γ), while restoring immunoglobulin levels (IgA, IgE, IgG). Additionally, it improved pulmonary function indices, including FEV1, FEV1/FVC and PEF. No significant differences were observed in the incidence of adverse reactions between the two groups. TSA demonstrated that the total effective rate curve surpassed both the traditional and TSA boundaries, corroborating the clinical efficacy. According to the GRADE assessment, outcomes related to treatment efficacy, recurrence rate, IFN-γ, CD4+, and incidence of adverse reactions were rated as moderate-quality evidence, whereas the remaining outcomes were assessed as low-quality evidence.

Conclusion

The integration of Huaiqihuang granules with conventional Western medicine in the management of CVA significantly enhances clinical efficacy, reduces recurrence rates, improves immune parameters, restores pulmonary function, ameliorates inflammatory markers, and normalizes immunoglobulin levels, in comparison to the use of Western medicine alone.
许多咳嗽变异性哮喘(CVA)患者使用槐芪黄颗粒缓解症状。然而,缺乏对其治疗CVA的有效性和安全性的系统评价。方法计算机检索各类数据库,检索槐七黄颗粒联合西药治疗儿童CVA的随机对照试验(rct)。检索包括中国知网、网方、维普、PubMed、Web of Science、The Cochrane Library、Embase、Sinomed等8个数据库,涵盖截至2025年4月的文献。根据预先确定的纳入和排除标准对文章进行筛选和选择。评估纳入文章的质量,然后使用RevMan5.3进行meta分析。采用建议评估、发展和评价等级(Grade)系统对证据质量进行分级。采用TSA 0.9.5.10 beta软件进行试验序列分析(TSA)。结果共纳入17项随机对照试验,总样本量为1742例。结果表明,与单用西药相比,怀七黄颗粒联合西药治疗可显著提高临床疗效,降低复发率。该组合还改善了免疫参数,包括CD4+/CD8+,并调节炎症标志物,如炎症因子白介素-4 (IL-4)和干扰素-γ (IFN-γ),同时恢复免疫球蛋白水平(IgA, IgE, IgG)。FEV1、FEV1/FVC、PEF等肺功能指标均有改善。两组患者不良反应发生率无显著差异。TSA显示总有效率曲线超越传统和TSA边界,证实了临床疗效。根据GRADE评估,与治疗疗效、复发率、IFN-γ、CD4+和不良反应发生率相关的结果被评为中等质量证据,而其余结果被评估为低质量证据。结论与单用西药相比,槐芪黄颗粒联合西药治疗CVA临床疗效显著提高,复发率降低,免疫指标改善,肺功能恢复,炎症指标改善,免疫球蛋白水平正常化。
{"title":"Meta-analysis and trial sequential analysis of Huaiqihuang granules in treatment of cough variant asthma in pediatrics","authors":"Qiaoling Li,&nbsp;Jing Peng,&nbsp;Linhui Liu","doi":"10.1016/j.eujim.2025.102511","DOIUrl":"10.1016/j.eujim.2025.102511","url":null,"abstract":"<div><h3>Introduction</h3><div>Many individuals with cough variant asthma (CVA) utilize Huaiqihuang granules to alleviate symptoms. However, there is a lack of systematic reviews investigating its efficacy and safety for CVA.</div></div><div><h3>Methods</h3><div>A computer-based retrieval of various databases was conducted to search for randomized controlled trials (RCTs) on the treatment of CVA in children using Huaiqihuang granules combined with Western medicine. The search encompassed eight databases, including China National Knowledge Infrastructure (CNKI), Wangfang, VIP (VIP Information Co.Ltd.), PubMed, Web of Science, The Cochrane Library, Embase, and Sinomed database, and covered literature up to April 2025. Articles were screened and selected based on predefined inclusion and exclusion criteria. The quality of the included articles was assessed, followed by a meta-analysis using RevMan5.3. The quality of evidence was graded using the Grade of Recommendations Assessment, Development, and Evaluation (GRADE) system. Additionally, trial sequential analysis (TSA) was performed using TSA 0.9.5.10 beta software.</div></div><div><h3>Results</h3><div>A total of 17 RCTs were included in the analysis, encompassing a total sample size of 1,742 patients. Results showed that the combination of Huaiqihuang granules with conventional Western medicine significantly enhanced clinical efficacy and reduced recurrence rates compared to Western medicine alone. This combination also improved immune parameters, including CD4+/CD8+, and modulated inflammatory markers such as inflammatory factors interleukin-4 (IL-4) and interferon-gamma (IFN-γ), while restoring immunoglobulin levels (IgA, IgE, IgG). Additionally, it improved pulmonary function indices, including FEV1, FEV1/FVC and PEF. No significant differences were observed in the incidence of adverse reactions between the two groups. TSA demonstrated that the total effective rate curve surpassed both the traditional and TSA boundaries, corroborating the clinical efficacy. According to the GRADE assessment, outcomes related to treatment efficacy, recurrence rate, IFN-γ, CD4+, and incidence of adverse reactions were rated as moderate-quality evidence, whereas the remaining outcomes were assessed as low-quality evidence.</div></div><div><h3>Conclusion</h3><div>The integration of Huaiqihuang granules with conventional Western medicine in the management of CVA significantly enhances clinical efficacy, reduces recurrence rates, improves immune parameters, restores pulmonary function, ameliorates inflammatory markers, and normalizes immunoglobulin levels, in comparison to the use of Western medicine alone.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"78 ","pages":"Article 102511"},"PeriodicalIF":1.9,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144523261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global trends and hotspots in acupuncture for hypertension: a bibliometric study from 1994 to 2024 针灸治疗高血压的全球趋势和热点:1994 - 2024年文献计量学研究
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-06-04 DOI: 10.1016/j.eujim.2025.102510
Yun-Hua Zheng , Wei Zheng , Jian-Yu Liu

Introduction

Growing interest in non-pharmacological hypertension management has led to increased research in acupuncture as a potential treatment. This bibliometric analysis examines the global research landscape of acupuncture for hypertension using CiteSpace and VOS Viewer software. By analyzing publication trends, key contributors, and collaborative networks, we summarize the current state of research, identify emerging hotspots, and outline future directions in this rapidly evolving field.

Methods

We conducted a comprehensive literature search in the Web of Science Core Collection (WOSCC), including the Science Citation Index Expanded (SCI-E) and Emerging Sources Citation Index (ESCI) databases, covering publications from 1994 to 2024. Bibliometric analysis and knowledge mapping were performed using CiteSpace (version 6.2.R4) and VOS Viewer (version 1.6.18) to analyze publication trends, research collaborations, and thematic evolution.

Results

The analysis revealed a consistent upward trend in annual publications from 1994 to 2024, with China emerging as the most productive country in this research domain. Key thematic clusters identified through keyword analysis included "acupuncture," "stimulation," "blood pressure regulation," and "electroacupuncture." Co-citation analysis demonstrated significant research intensity for "systemic hypertension" (cluster strength: 6.94, 2015–2019), "randomized controlled trials" (4.31, 2022–2024), and "neurons" (3.9, 2012–2013). The study by Frank A Flachskampf et al. (burst strength = 8.48) showed the strongest citation burst.

Conclusion

Our bibliometric analysis reveals a marked surge in research output and scientific engagement, underscoring acupuncture’s expanding role as a therapeutic intervention for hypertension. The field exhibits robust growth potential, driven by intensifying global collaboration among leading institutions and interdisciplinary research teams.
随着人们对非药物高血压治疗的兴趣日益浓厚,针灸作为一种潜在的治疗方法的研究也越来越多。本文使用CiteSpace和VOS Viewer软件对针灸治疗高血压的全球研究现状进行了文献计量分析。通过分析出版趋势、主要贡献者和合作网络,我们总结了研究现状,确定了新兴热点,并概述了这个快速发展领域的未来方向。方法对Web of Science Core Collection (WOSCC)进行全面的文献检索,包括Science Citation Index Expanded (SCI-E)和Emerging Sources Citation Index (ESCI)数据库,检索时间为1994 - 2024年。使用CiteSpace (version 6.2.R4)和VOS Viewer (version 1.6.18)进行文献计量分析和知识图谱分析,分析出版趋势、研究合作和专题演变。结果分析显示,从1994年到2024年,中国的年度出版物数量呈持续上升趋势,中国成为该研究领域产量最高的国家。通过关键词分析确定的关键主题集群包括“针灸”、“刺激”、“血压调节”和“电针”。共引分析显示,“全体性高血压”(聚类强度:6.94,2015-2019)、“随机对照试验”(聚类强度:4.31,2022-2024)和“神经元”(聚类强度:3.9,2012-2013)的研究强度显著。Frank A Flachskampf等人的研究(burst strength = 8.48)表现出最强的引文爆发。我们的文献计量分析显示,研究产出和科学参与显著增加,强调了针灸作为高血压治疗干预措施的作用日益扩大。在全球领先机构和跨学科研究团队加强合作的推动下,该领域显示出强劲的增长潜力。
{"title":"Global trends and hotspots in acupuncture for hypertension: a bibliometric study from 1994 to 2024","authors":"Yun-Hua Zheng ,&nbsp;Wei Zheng ,&nbsp;Jian-Yu Liu","doi":"10.1016/j.eujim.2025.102510","DOIUrl":"10.1016/j.eujim.2025.102510","url":null,"abstract":"<div><h3>Introduction</h3><div>Growing interest in non-pharmacological hypertension management has led to increased research in acupuncture as a potential treatment. This bibliometric analysis examines the global research landscape of acupuncture for hypertension using CiteSpace and VOS Viewer software. By analyzing publication trends, key contributors, and collaborative networks, we summarize the current state of research, identify emerging hotspots, and outline future directions in this rapidly evolving field.</div></div><div><h3>Methods</h3><div>We conducted a comprehensive literature search in the Web of Science Core Collection (WOSCC), including the Science Citation Index Expanded (SCI-E) and Emerging Sources Citation Index (ESCI) databases, covering publications from 1994 to 2024. Bibliometric analysis and knowledge mapping were performed using CiteSpace (version 6.2.R4) and VOS Viewer (version 1.6.18) to analyze publication trends, research collaborations, and thematic evolution.</div></div><div><h3>Results</h3><div>The analysis revealed a consistent upward trend in annual publications from 1994 to 2024, with China emerging as the most productive country in this research domain. Key thematic clusters identified through keyword analysis included \"acupuncture,\" \"stimulation,\" \"blood pressure regulation,\" and \"electroacupuncture.\" Co-citation analysis demonstrated significant research intensity for \"systemic hypertension\" (cluster strength: 6.94, 2015–2019), \"randomized controlled trials\" (4.31, 2022–2024), and \"neurons\" (3.9, 2012–2013). The study by Frank A Flachskampf et al. (burst strength = 8.48) showed the strongest citation burst.</div></div><div><h3>Conclusion</h3><div>Our bibliometric analysis reveals a marked surge in research output and scientific engagement, underscoring acupuncture’s expanding role as a therapeutic intervention for hypertension. The field exhibits robust growth potential, driven by intensifying global collaboration among leading institutions and interdisciplinary research teams.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"78 ","pages":"Article 102510"},"PeriodicalIF":1.9,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144522387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Herbal medicine treatment patterns for Parkinson’s disease: A nationwide population-based medical claims database in South Korea 帕金森病的草药治疗模式:韩国基于全国人口的医疗索赔数据库
IF 1.9 4区 医学 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-05-31 DOI: 10.1016/j.eujim.2025.102509
Jiyun Cha , Ojin Kwon , Changsop Yang , In-chan Seol , Jung-Hee Jang

Introduction

Parkinson’s disease (PD) is characterized by heterogeneous symptoms and long disease progression and requires individualized treatment. This study aimed to elucidate large-scale herbal medicine patterns according to age, duration of disease progression, and various detailed symptoms of PD, as well as examine comorbidities to build a basis for clinical applications.

Methods

We analyzed data from the Korean National Health Insurance System cohort database regarding patients with PD who received herbal medicines between 2014 and 2020. We identified 10,060 patients with various prescription patterns based on age and PD duration. Additionally, to estimate the potential therapeutic mechanisms of insured herbal medicines for the clinical symptoms of PD, we conducted a literature review of the results of clinical and preclinical studies.

Results

The overall insurance-covered herbal medicine prescriptions for patients with PD had increased in both the number of prescriptions and patients over time. The herbal medicine use rate in patients with PD was the highest between ages 70 and 79 years and within 3 years of PD onset. Doinseunggi-tang, Haengso-tang, and Palmul-tang were the most frequently used herbal medicines. The most common comorbidities diagnosed along with PD were musculoskeletal and digestive diseases.

Conclusion

Some insurance-covered herbal medicines are frequently used among patient groups in a specific age group or duration of disease, and our literature review indicates a correlation between the mechanism of action of these herbal medicines and a specific subgroup of patients with PD. To validate these results and draw meaningful conclusions that reflect the realities of Korean medicine clinical practice, including non-reimbursed treatments, further prospective large-scale clinical trials considering age and disease progression duration are required.

Funding

This work was supported by a National Research Foundation of Korea grant.
帕金森病(PD)的特点是症状异质性和病程进展长,需要个体化治疗。本研究旨在根据PD的年龄、病程和各种详细症状,阐明大规模的草药用药模式,并检查合并症,为临床应用奠定基础。方法:我们分析了韩国国民健康保险系统队列数据库中2014年至2020年期间接受草药治疗的PD患者的数据。我们根据年龄和PD病程确定了10060例不同处方模式的患者。此外,为了评估参保草药对PD临床症状的潜在治疗机制,我们对临床和临床前研究结果进行了文献综述。结果随着时间的推移,PD患者参保中草药处方数量和参保人数均呈增加趋势。PD患者中草药使用率在70 ~ 79岁及发病3年内最高。使用频率最高的是道成汤、杏素汤、八木汤。PD最常见的合并症是肌肉骨骼和消化系统疾病。结论某些参保草药在特定年龄组或病程的患者群体中经常使用,我们的文献综述表明这些草药的作用机制与特定亚组PD患者之间存在相关性。为了验证这些结果并得出有意义的结论,以反映韩国医学临床实践的现实,包括无报销治疗,需要进一步考虑年龄和疾病进展时间的前瞻性大规模临床试验。这项工作得到了韩国国家研究基金会的资助。
{"title":"Herbal medicine treatment patterns for Parkinson’s disease: A nationwide population-based medical claims database in South Korea","authors":"Jiyun Cha ,&nbsp;Ojin Kwon ,&nbsp;Changsop Yang ,&nbsp;In-chan Seol ,&nbsp;Jung-Hee Jang","doi":"10.1016/j.eujim.2025.102509","DOIUrl":"10.1016/j.eujim.2025.102509","url":null,"abstract":"<div><h3>Introduction</h3><div>Parkinson’s disease (PD) is characterized by heterogeneous symptoms and long disease progression and requires individualized treatment. This study aimed to elucidate large-scale herbal medicine patterns according to age, duration of disease progression, and various detailed symptoms of PD, as well as examine comorbidities to build a basis for clinical applications.</div></div><div><h3>Methods</h3><div>We analyzed data from the Korean National Health Insurance System cohort database regarding patients with PD who received herbal medicines between 2014 and 2020. We identified 10,060 patients with various prescription patterns based on age and PD duration. Additionally, to estimate the potential therapeutic mechanisms of insured herbal medicines for the clinical symptoms of PD, we conducted a literature review of the results of clinical and preclinical studies.</div></div><div><h3>Results</h3><div>The overall insurance-covered herbal medicine prescriptions for patients with PD had increased in both the number of prescriptions and patients over time. The herbal medicine use rate in patients with PD was the highest between ages 70 and 79 years and within 3 years of PD onset. Doinseunggi-tang, Haengso-tang, and Palmul-tang were the most frequently used herbal medicines. The most common comorbidities diagnosed along with PD were musculoskeletal and digestive diseases.</div></div><div><h3>Conclusion</h3><div>Some insurance-covered herbal medicines are frequently used among patient groups in a specific age group or duration of disease, and our literature review indicates a correlation between the mechanism of action of these herbal medicines and a specific subgroup of patients with PD. To validate these results and draw meaningful conclusions that reflect the realities of Korean medicine clinical practice, including non-reimbursed treatments, further prospective large-scale clinical trials considering age and disease progression duration are required.</div></div><div><h3>Funding</h3><div>This work was supported by a National Research Foundation of Korea grant.</div></div>","PeriodicalId":11932,"journal":{"name":"European Journal of Integrative Medicine","volume":"77 ","pages":"Article 102509"},"PeriodicalIF":1.9,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144481249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Integrative Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1